Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension

Sun Pharma Announce FDA Approval of Xelpros to Treat Open-angle Glaucoma or Ocular Hypertension

Source: 
CP Wire
snippet: 
  • Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK)
  • BAK is associated with increased incidence of Ocular Surface Disease (OSD)